Avanz Pharma Private Limited

Avanz Pharma Private Limited - chemicals in Chennai, Tamil Nadu, India. Directors, charges & compliance details.
CIN U24233TN2021PTC145300 Incorporated 05 August 2021 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company chemicals MSME · Micro
Data last updated
Revenue · FY 2025
₹21.32 Lakh
▼ 43% YoY
Net loss · FY 2025
₹6.31 Lakh
Net margin -29.6%
EBITDA · FY 2025
-₹4.11 Lakh
EBITDA margin -19.3%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹15 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings

About Avanz Pharma Private Limited

Data last updated:

Avanz Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 05 August 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24233TN2021PTC145300.

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Nepolian Bounapart Deivanayagam and Ramasamy Sivasubramanian.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 104B And 105 Vgn Shanthi Nagar Mahatma Gandhi Street Ambattur, Chennai, Tamil Nadu, India – 600058.

As per the financials filed for FY 2025, the company reported a revenue of ₹21.32 Lakh, a decline of 43% compared to the previous year. For the same year it recorded a net loss of ₹6.31 Lakh (net margin -29.6%) and EBITDA of -₹4.11 Lakh (EBITDA margin -19.3%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years.

As per MCA filings, the company has open charges of ₹15 Lakh on record.

Avanz Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0084698).

Company details

CIN U24233TN2021PTC145300
Registration Number 145300
Incorporation Date 05 August 2021
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0084698

Recognitions & Rankings of Avanz Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-TN-02-0084698

Contact details

Avanz Pharma Private Limited's registered office is in Chennai, Tamil Nadu.

  • Registered Address
    Plot No. 104B And 105 Vgn Shanthi Nagar Mahatma Gandhi Street Ambattur, Chennai, Tamil Nadu, India – 600058
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Avanz Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Avanz Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Avanz Pharma Private Limited, buy the company report.

Financials of Avanz Pharma Private Limited

FY 2025 filings available

Avanz Pharma Private Limited reported revenue of ₹21.32 Lakh (down 43% YoY) for FY 2025.

Revenue · FY 2025
₹21.32 Lakh ▼ 43%
Net loss · FY 2025
₹6.31 Lakh margin -29.6%
EBITDA · FY 2025
-₹4.11 Lakh margin -19.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 43%
3 years · compounded
▲ 52%
EBITDA CAGR growth
1 year
▼ 541%
3 years · compounded
▲ 4%

Revenue fell 43% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 52%. EBITDA fell 541% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹4.11 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹6.31 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-19.3%
Net Profit Margin-29.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Avanz Pharma Private Limited, buy the company report.

Board of directors of Avanz Pharma Private Limited

Avanz Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Nepolian Bounapart DeivanayagamDirector05 Aug 20215 Years 2 MonthsCurrent
Ramasamy SivasubramanianDirector05 Aug 20215 Years 2 MonthsCurrent

Peer comparison

Avanz Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Maxxon Lubricants Private Limited₹21.33 Lakh (FY 2025)3.0%Ahmedabad, Gujarat, India
Vivavera Private Limited₹21.33 Lakh (FY 2023)47.0%Surat, Gujarat, India
Dalela Business Solutions Private Limited₹21.33 Lakh (FY 2016)110.0%Lucknow, Uttar Pradesh, India
Mercato Marketing India Private Limited₹21.33 Lakh (FY 2020)Kottarakkara, Kerala, India
Ritudhara Marketing Private Limited₹21.33 Lakh (FY 2018)-30.0%Kolkata, West Bengal, India
Avanz Pharma Private Limitedthis company₹21.32 Lakh (FY 2025)-₹6.31 Lakh-29.6%-43.0%Chennai, Tamil Nadu, India
Infingrow Smart Technologies Private Limited₹21.32 Lakh (FY 2024)-52.0%Chennai, Tamil Nadu, India
Exact MFD Private Limited₹21.32 Lakh (FY 2020)55.0%Chennai, Tamil Nadu, India
Kops International Limited₹21.32 Lakh (FY 2025)-50.0%Faridabad, Haryana, India
Anmol Merchants Private Limited₹21.31 Lakh (FY 2025)4.0%Kolkata, West Bengal, India
Premsudha Exports Private Limited₹21.31 Lakh (FY 2025)-21.0%Mumbai, Maharashtra, India

To see the full peer comparison of Avanz Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹15 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.15 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Aug 2023100792665Others₹15 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Avanz Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Avanz Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Avanz Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Nepolian Bounapart Deivanayagam was appointed as Director on 05 Aug 2021.

AGM
Avanz Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Avanz Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Others amounted to Rs. 15.00 Lakh with Charge ID 100792665 was registered on 30 Aug 2023.
Appointed
Nepolian Bounapart Deivanayagam was appointed as Director.
Appointed
Ramasamy Sivasubramanian was appointed as Director.
Incorporation
05 Aug 2021
Avanz Pharma Private Limited was registered on 05 Aug 2021 with Roc Chennai & aged 5 years 2 months as per MCA records.

Frequently asked questions

Avanz Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 05 August 2021 (5+ years old) and is registered under CIN U24233TN2021PTC145300.

Avanz Pharma has 2 current directors:

The latest financial statements of Avanz Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Avanz Pharma is U24233TN2021PTC145300. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Avanz Pharma was incorporated on 05 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Avanz Pharma by revenue are Maxxon Lubricants Private Limited, Vivavera Private Limited, Dalela Business Solutions Private Limited, Mercato Marketing India Private Limited, Ritudhara Marketing Private Limited and 5 more, all in the same principal business activity (wholesale trading).

Nepolian Bounapart Deivanayagam was appointed as Director on 05 Aug 2021. Ramasamy Sivasubramanian was appointed as Director on 05 Aug 2021.

Yes, Avanz Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0084698).

The registered office of Avanz Pharma is at Plot No. 104B And 105 Vgn Shanthi Nagar Mahatma Gandhi Street Ambattur, Chennai, Tamil Nadu, India – 600058.

Avanz Pharma operates in the chemicals industry, in the manufacturing segment.

Avanz Pharma has open charges of ₹15 Lakh and no satisfied charges on record as per latest MCA filings.